CompletedNot Applicable

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.

France22 participantsStarted 2019-09-30

Plain-language summary

From the medical records of a series of patients operated on for incident grade II and III glioma, the primary objective is to evaluate the correlation between the molecular profile of tumours and preoperative imaging data (by FDG and FDOPA PET-scan and multimodal MRI).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject 18 years of age or older, having been informed of the research * Subject operated on with an incident glioma of grade II or III, histologically confirmed (WHO 2016 classification) * Subject for which all preoperative imaging data is available (MRI, FDG and FDOPA PET-scan) * Subject for which molecular data of the lesion are available Exclusion Criteria: * Subject having signified his opposition to the use of his medical data * Subject under safeguard of justice, guardianship or trusteeship * Subject with incomplete or missing part of the molecular and/or imaging data

What they're measuring

Primary outcome

Timeframe: 4 years

Trial details

NCT IDNCT04461002

SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Glioma trials